**TECH: An Update on the New ORAL Antivirals AND Monoclonal Antibodies for Anti-SARS-CoV-2


Date: Feb 26, 2022 10:00 AM - 11:00 AM

Fee

$0.00

CE Hours

1.00

CE Units

0.100

Registration closes on Apr 09, 2022 01:00 AM

Activity Type

Knowledge

Target Audience(s)

Pharmacists

Accreditation(s)

Accreditation Council for Pharmacy Education
Accreditation Statement: Howard University College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

 

Registration Closed  

Objectives

  • Recognize existing and novel therapeutic options for mild-moderate COVID patients
  • Recall important characteristics of phase III trials of novel therapeutic options
  • Identify NIH guidelines to recommend appropriate therapeutic options for mild-moderate COVID & HIV patients

Speaker(s)/Author(s)

Andrew A. Yabusaki, PharmD, BCPS, RPh
Assistant Clinical Professor, HOWARD UNIVERSITY

Activity Number

0010-0000-22-004-L01-T
Date: 02/26/22
Time: 10:00 AM - 11:00 AM

CE Hours

1.00
Registration Closed